Overslaan en naar de inhoud gaan
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NL
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Subscribe
Filters
Filters
Verversen
Herstel
Icon After
Datum
Omschakelen Zichtbaarheid
All
Vandaag
Deze week
This month
Custom date range
From
To
Topic
Omschakelen Zichtbaarheid
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Omschakelen Zichtbaarheid
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 1 - 28 of 28 results
Released
Company
Title
Industry
Topic
24 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis sera à San Francisco durant la JP Morgan Healthcare Conference de 2025
20103010 Biotechnology
Legal
24 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
20103010 Biotechnology
Legal
23 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis showcased the OBA program in obesity at the 17th SCWD international congress
20103010 Biotechnology
Legal
23 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis a présenté le programme OBA dans l\'obésité lors du 17ème congrès international de la SCWD
20103010 Biotechnology
Legal
02 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis participe à la 17ème édition du congrès SCWD et organise un Obesity Investor Call
20103010 Biotechnology
Legal
02 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
20103010 Biotechnology
Legal
30 Sep 2024
23:00 CEST
BIOPHYTIS
Biophytis publie ses comptes semestriels et fait le point sur ses activités
20103010 Biotechnology
General meeting / Board Meeting
30 Sep 2024
23:00 CEST
BIOPHYTIS
Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
20103010 Biotechnology
General meeting / Board Meeting
22 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
20103010 Biotechnology
Other subject
22 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis déploie sa stratégie de partenariats et signe deux contrats avec des agents locaux en Asie
20103010 Biotechnology
Other subject
11 Jul 2024
07:01 CEST
BIOPHYTIS
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
20103010 Biotechnology
Other subject
11 Jul 2024
07:01 CEST
BIOPHYTIS
Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
20103010 Biotechnology
Other subject
01 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
20103010 Biotechnology
Other subject
01 Jul 2024
07:00 CEST
BIOPHYTIS
Biophy(s a présenté les résultats de l\'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
20103010 Biotechnology
Other subject
25 Jun 2024
23:00 CEST
BIOPHYTIS
RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
20103010 Biotechnology
Other subject
25 Jun 2024
23:00 CEST
BIOPHYTIS
RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
20103010 Biotechnology
Other subject
20 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
20103010 Biotechnology
Other subject
20 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
20103010 Biotechnology
Other subject
19 Jun 2024
23:00 CEST
BIOPHYTIS
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
20103010 Biotechnology
Other subject
19 Jun 2024
23:00 CEST
BIOPHYTIS
Biophytis extends its contract with Atlas to secure financing for its business activities
20103010 Biotechnology
Other subject
12 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
20103010 Biotechnology
Other subject
12 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
20103010 Biotechnology
Other subject
10 Jun 2024
08:18 CEST
BIOPHYTIS
Biophytis annonce le dépôt d\'une demande d\'IND auprès de la FDA pour son étude de phase 2 dans l\'obésité
20103010 Biotechnology
Other subject
10 Jun 2024
08:18 CEST
BIOPHYTIS
Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
20103010 Biotechnology
Other subject
07 Jun 2024
08:23 CEST
BIOPHYTIS
Combined General Meeting of June 24, 2024
20103010 Biotechnology
Other subject
07 Jun 2024
08:23 CEST
BIOPHYTIS
Assemblée générale mixte du 24 juin 2024
20103010 Biotechnology
Other subject
14 May 2024
07:00 CEST
BIOPHYTIS
Biophytis announces the design of its phase 2 OBA clinical study in obesity
20103010 Biotechnology
Other subject
14 May 2024
07:00 CEST
BIOPHYTIS
Biophytis annonce le design de son étude clinique de phase 2 OBA dans l\'obésité
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markten
Amsterdam
Cash Producten
Aandelen
AEX index Stocks
AEX ESG Stocks
Indices
Beleggingsfondsen
Obligaties
ETFs
Gestructureerde producten
Derivaten
Indexopties
Indexfutures
Aandelenopties
Dividend derivativen
Aandelenfutures
Quote Vendor Codes
Company regulated news
Latest
Archive
Euronext Brussel
Cash Producten
Aandelen
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Obligaties
ETFs
Gestructureerde producten
Derivaten
Indexfutures
Aandelenopties
Aandelenfutures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Euronext Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Euronext Lissabon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Euronext Parijs
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Aandelen
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Beleggingsfondsen
Directory
ESG Funds
Oslo Mutual Funds
Obligaties
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Gestructureerde producten
Directory / search
Handel tijdens een Bid-Only situatie
Turbo handel in Nederland
Aandelen en FX-derivaten
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
DSP
Education
Academy
Stocks Education
Option education
Our Indices
Educational videos
News & Insights
Hulpmiddelen
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Waar vind ik?